STING1 and neoplasm: Acute activation is generally advantageous; for instance, in antiviral or antitumor immunity, transient and robust activation of the STING pathway through pharmacological agents, such as STING agonists, or radiotherapy can effectively stimulate the immune system to eradicate pathogens or tumor cells (42).